U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C30H29N5O4S.ClH
Molecular Weight 592.108
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FIDUXOSIN HYDROCHLORIDE

SMILES

Cl.[H][C@]12CN(CCCCN3C(=O)NC4=C(SC5=C4N=C(C=N5)C6=CC=CC=C6)C3=O)C[C@@]1([H])C7=C(OC2)C=CC=C7OC

InChI

InChIKey=OFPMGRPQOZABPO-GZJHNZOKSA-N
InChI=1S/C30H29N5O4S.ClH/c1-38-22-10-7-11-23-24(22)20-16-34(15-19(20)17-39-23)12-5-6-13-35-29(36)27-25(33-30(35)37)26-28(40-27)31-14-21(32-26)18-8-3-2-4-9-18;/h2-4,7-11,14,19-20H,5-6,12-13,15-17H2,1H3,(H,33,37);1H/t19-,20-;/m1./s1

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C30H29N5O4S
Molecular Weight 555.647
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

FIDUXOSIN is a selective alpha1-adrenoceptor antagonist with higher affinity for alpha1A-adrenoceptors and for alpha1D-adrenoceptors than for alpha1B-adrenoceptors. It was in clinical trials for the treatment of benign prostatic hyperplasia.

Approval Year

PubMed

PubMed

TitleDatePubMed
Effect of fiduxosin, an antagonist selective for alpha(1A)- and alpha(1D)-adrenoceptors, on intraurethral and arterial pressure responses in conscious dogs.
2002 Feb
Preclinical pharmacology of fiduxosin, a novel alpha(1)-adrenoceptor antagonist with uroselective properties.
2002 Feb
Patents

Sample Use Guides

Fiduxosin had higher affinity for cloned human alpha(1a)- (0.16 nM) and alpha(1d)-adrenoceptors (0.92 nM) in radioligand binding studies compared with alpha(1b)-adrenoceptors (25 nM).
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:25:01 UTC 2023
Edited
by admin
on Fri Dec 15 16:25:01 UTC 2023
Record UNII
UYV23L1N89
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FIDUXOSIN HYDROCHLORIDE
USAN  
USAN  
Official Name English
PYRAZINO(2',3':4,5)THIENO(3,2-D)PYRIMIDINE-2,4(1H,3H)-DIONE, 8-PHENYL-3-(4-((3AR,9BR)-1,3A,4,9B-TETRAHYDRO-9-METHOXY(1)BENZOPYRANO(3,4-C)PYRROL-2(3H)-YL)BUTYL)-, MONOHYDROCHLORIDE
Common Name English
FIDUXOSIN HCL
Common Name English
8-PHENYL-3-(4-)(3AR,9BR)-1,3A,4,9B-TETRAHYDRO-9-METHOXY(1)BENZOPYRANO(3,4-C)PYRROL-2(3H)-YL)BUTYL)PYRAZINO(2',3':4,5)THIENO(3,2-D)PYRIMIDINE-2,4(1H,3H)-DIONE MONOHYDROCHLORIDE
Common Name English
ABT-980
Code English
A-185980.1
Code English
FIDUXOSIN HYDROCHLORIDE [USAN]
Common Name English
A-1859801
Code English
Classification Tree Code System Code
NCI_THESAURUS C29713
Created by admin on Fri Dec 15 16:25:01 UTC 2023 , Edited by admin on Fri Dec 15 16:25:01 UTC 2023
Code System Code Type Description
NCI_THESAURUS
C81371
Created by admin on Fri Dec 15 16:25:01 UTC 2023 , Edited by admin on Fri Dec 15 16:25:01 UTC 2023
PRIMARY
USAN
LL-04
Created by admin on Fri Dec 15 16:25:01 UTC 2023 , Edited by admin on Fri Dec 15 16:25:01 UTC 2023
PRIMARY
EPA CompTox
DTXSID1049013
Created by admin on Fri Dec 15 16:25:01 UTC 2023 , Edited by admin on Fri Dec 15 16:25:01 UTC 2023
PRIMARY
CAS
208992-74-9
Created by admin on Fri Dec 15 16:25:01 UTC 2023 , Edited by admin on Fri Dec 15 16:25:01 UTC 2023
PRIMARY
ChEMBL
CHEMBL1256183
Created by admin on Fri Dec 15 16:25:01 UTC 2023 , Edited by admin on Fri Dec 15 16:25:01 UTC 2023
PRIMARY
FDA UNII
UYV23L1N89
Created by admin on Fri Dec 15 16:25:01 UTC 2023 , Edited by admin on Fri Dec 15 16:25:01 UTC 2023
PRIMARY
PUBCHEM
172306
Created by admin on Fri Dec 15 16:25:01 UTC 2023 , Edited by admin on Fri Dec 15 16:25:01 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY